TrialArthritis & rheumatology (Hoboken, N.J.)2020

Pulmonary Adverse Events in Patients Receiving Low-Dose Methotrexate in the Randomized, Double-Blind, Placebo-Controlled Cardiovascular Inflammation Reduction Trial.

Jeffrey A Sparks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.